Evidence map›Paper›PMID 31477775›Full record

ArticleScientific reports2019

miR-146a Deficiency Accelerates Hepatic Inflammation Without Influencing Diet-induced Obesity in Mice.

Aida Javidan, Weihua Jiang, Michihiro Okuyama, Devi Thiagarajan, Lihua Yang, Jessica J Moorleghen, Latha Muniappan, Venkateswaran Subramanian

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.1field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 22 citations in OpenAlex.

  1. miR-146a mimic therapy protects against platelet-mediated thrombosis.Molecular therapy : the journal of the American Society of Gene Therapy · 2026
    Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Antioxidant and Anti-Inflammatory Activity ofAntioxidants (Basel, Switzerland) · 2021
    Article
  9. Article
  10. miR-146a regulates insulin sensitivity via NPR3.Cellular and molecular life sciences : CMLS · 2021
    Article
  11. Review
  12. Article
  13. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Aida JavidanSaha Cardiovascular Research Center, University of Kentucky, Lexington, KY, USA.
Weihua JiangSaha Cardiovascular Research Center, University of Kentucky, Lexington, KY, USA.
Michihiro OkuyamaSaha Cardiovascular Research Center, University of Kentucky, Lexington, KY, USA.
Devi ThiagarajanSaha Cardiovascular Research Center, University of Kentucky, Lexington, KY, USA.
Lihua YangSaha Cardiovascular Research Center, University of Kentucky, Lexington, KY, USA.
Jessica J MoorleghenSaha Cardiovascular Research Center, University of Kentucky, Lexington, KY, USA.
Latha MuniappanSaha Cardiovascular Research Center, University of Kentucky, Lexington, KY, USA.
Venkateswaran SubramanianSaha Cardiovascular Research Center, University of Kentucky, Lexington, KY, USA. venkat.subramanian@uky.edu.
University of Kentucky · US

Funding

The role of IKKß in linking obesity to adipose tissue inflammation and adipogeneP20GM103527 · NIGMS · UNIVERSITY OF KENTUCKY · PI MORRIS, ANDREW J · 2012 to 2017
$13.7M
Pilot Projects ProgramP30GM127211 · NIGMS · UNIVERSITY OF KENTUCKY · PI CASSIS, LISA A · 2018 to 2022
$5.7M
Calpains and Abdominal Aortic AneurysmsR01HL130086 · NHLBI · UNIVERSITY OF KENTUCKY · PI SUBRAMANIAN, VENKATESWARAN · 2017 to 2020
$1.9M
NHLBI NIH HHS R01 HL130086NIGMS NIH HHS P20 GM103527NIGMS NIH HHS P30 GM127211
6 · The paper itself

Abstract

miR-146a, an anti-inflammatory microRNA, is shown to be a negative regulator of adipocyte inflammation. However, the functional contribution of miR-146a in the development of obesity is not defined. In order to determine whether miR-146a influences diet-induced obesity, mice that were either wild type (WT) or miR-146a deficient (KO) were fed with high (60% kcal) fat diet (HFD) for 16 weeks. Deficiency of miR-146a did not influence obesity measured as HFD-induced body weight and fat mass gain, or metabolism of glucose and insulin tolerance. In addition, adipocyte apoptosis, adipose tissue collagen and macrophage accumulation as detected by TUNEL, Picro Sirius and F4/80 immunostaining, respectively, were comparable between the two groups of mice. Although, miR-146a deficiency had no influence on HFD-induced hepatic lipid accumulation, interestingly, it significantly increased obesity-induced inflammatory responses in liver tissue. The present study demonstrates that miR-146a deficiency had no influence on the development of HFD-induced obesity and adipose tissue remodeling, whereas it significantly increased hepatic inflammation in obese mice. This result suggests that miR-146a regulates hepatic inflammation during development of obesity.

Indexed as

Diet, High-FatAdipocytesAdipose TissueAdiposityAnimalsCell DeathFemaleGlucose Tolerance TestInflammationInsulinLiverLiver CirrhosisMacrophagesMaleMice, Inbred C57BLMicroRNAsInsulinMicroRNAsMirn146 microRNA, mouse

Identifiers

PMID31477775
PMCPMC6718417
OpenAlexW2970778864

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.